Search for: "Mylan Pharmaceuticals v. FDA"
Results 101 - 120
of 233
Sort by Relevance
|
Sort by Date
18 Jul 2011, 8:21 am
Mylan, Takeda v. [read post]
18 Jul 2011, 8:21 am
Mylan, Takeda v. [read post]
13 Jul 2011, 3:04 am
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog) Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re… [read post]
6 Jul 2011, 2:21 am
(Patent Baristas) US: FDA’s Chief Counsel, Ralph Tyler, set to leave FDA (FDA Law Blog) US: Docs at BIO: Steve Burrill’s state of the biotechnology industry report 2011 (Patent Docs) US: Counterfeiting: White House IP Czar Victoria Espinel on working with corporations (BIOtechNOW) US: Banning gene patents will promote innovation? [read post]
30 Jun 2011, 2:13 pm
I received notice from PriorSmart today that on June 28, 2011 the case Somaxon Pharmaceuticals Inc. v. [read post]
29 Jun 2011, 3:34 am
Demahy (FDA Law Blog) Modafinil – UK: EWHC (Pat): Patents not infringed but obvious – Cephalon, Inc v Orchid Europe (EPLAW) (IPKat) Paracetamol – Nigerian court slaps huge damages on GSK in Panadol dispute (Afro-IP) Silenor (Doxepin) – US: Somaxon files patent infringement suit against Mylan for trying to market generic Silenor (GenericsWeb) Suprane (Desfluorane) – US: FDA grants Baxter’s petition for second 30-month stay… [read post]
27 Jun 2011, 8:41 am
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
24 Jun 2011, 3:25 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' supplemental briefRespondents' supplemental briefPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011Filed: May 26, 2011… [read post]
15 Jun 2011, 4:56 am
Mylan Inc. et al. [read post]
31 May 2011, 8:38 pm
Labs. v. [read post]
Obama Administration Urges Supreme Court to Grant Certiorari in Case on Orange Book Patent Use Codes
30 May 2011, 9:49 pm
PIRG; the Generic Pharmaceutical Association (GPhA); Mylan; and Teva. [read post]
27 May 2011, 8:56 am
Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs)… [read post]
18 May 2011, 12:33 am
Sun Pharmaceuticals on question of obviousness-type double patenting (Patent Docs) (IPBiz) Glumetza (Metformin) – US: Depomed receives notice of Para IV certification against patents from second ANDA filer, Sun Pharmaceutical (GenericsWeb) Myfortic7 (Mycophenolate) – US: Novartis files patent infringement complaint against Teva in response to Para IV certification filing (Patent Docs) NuvaRing (Etonogestrel, Estradiol) – US: ALJ Luckern sets procedural schedule in… [read post]
11 May 2011, 4:54 am
Highlights this week included: US: Federal Trade Commission issues report on reverse settlement agreements in FY2010 (Patent Docs) (Orange Book Blog) (FDA Law Blog) US: Billups-Rothenberg v. [read post]
4 May 2011, 4:13 am
Purepac Pharmaceutical, et. al. [read post]
28 Apr 2011, 3:18 pm
Even where a product’s risks were unavoidable, it required an independent balancing of risks and benefits – the kind of thing the FDA does – before the risks involved would be considered “apparently reasonable. [read post]
19 Apr 2011, 5:04 pm
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
15 Apr 2011, 6:02 am
Mylan Pharmaceuticals, Inc., 2009 WL 7115134, at *2 (N.D. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on… [read post]
